VTYX FY 2020 Earnings — Ventyx Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

VTYXVentyx Biosciences, Inc.

$1B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$7M

Net Income

-$28M

EPS (Diluted)

$-0.56

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$45,000

Balance Sheet

Total Assets

$245,000

Total Liabilities

$31M

Stockholders' Equity

-$31M

Cash & Equivalents

$244,000

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$7M	-$4M	-68.7%
Net Income	-$28M	-$4M	-529.9%